The activation of MasR increases NO production through the phosphoinositide 3-kinase (PI3K)/Akt/eNOS pathway and activates SHP-2 in endothelial cells, which counteracts AngII/AT1R-induced hypertension and VEC dysfunction [25]. The gene discussed is NOS3; the disease is hypertensive disorder.